C2BBe1 In Vivo Anti-Tumor Efficacy Assay

This assay is to provide C2BBe1-based In Vivo Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

C2BBe1

Human

The C2BBe1 (brush border expressing) cell line was cloned in 1988 from the Caco-2 cell line by limiting dilution.
The clone was selected on the basis of morphological homogeneity and exclusive apical villin localization.

Colorectal Adenocarcinoma; Colon Cancer

Oncology

In Vivo Anti-Tumor Efficacy Assay

C2BBe1-cell based In Vivo Anti-Tumor Efficacy Assay

After positive anti-tumor efficacy data is concluded using in vitro assays, we can start to initiate in vivo anti-tumor efficacy studies. Creative Biolabs offers a wide variety of PDX or CDX models to facilitate the efficacy studies. This assy will be used to evaluate the anti-tumor efficacy of your therapeutic candidates, such as small molecules, antibodies, CARTs or other biologics. Detailed group set up and other plans will be discussed according to your specific requirements.

Oncology In Vivo Assays